Jose Vieira - Procaps Group Chief Officer
| PROCW Stock | USD 0.01 0 8.03% |
Executive
Jose Vieira is Chief Officer of Procaps Group SA
| Age | 58 |
| Address | 9 Rue de Bitbourg, Luxembourg, Luxembourg, 1273 |
| Phone | 356 7995 6138 |
| Web | https://www.procapsgroup.com |
Procaps Group Management Efficiency
The company has return on total asset (ROA) of 0.0628 % which means that it generated a profit of $0.0628 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.3737 %, meaning that it generated $0.3737 on every $100 dollars invested by stockholders. Procaps Group's management efficiency ratios could be used to measure how well Procaps Group manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Procaps Group's Return On Tangible Assets are fairly stable compared to the past year. Return On Assets is likely to climb to 0.09 in 2024, whereas Return On Capital Employed is likely to drop 0.41 in 2024. At this time, Procaps Group's Return On Tangible Assets are fairly stable compared to the past year. Intangibles To Total Assets is likely to climb to 0.1 in 2024, whereas Non Current Assets Total are likely to drop slightly above 133.4 M in 2024.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Kathleen Fitzpatrick | Bausch Health Companies | N/A | |
| William Woodfield | Bausch Health Companies | N/A | |
| Seana Carson | Bausch Health Companies | 51 | |
| Sonya Ghobrial | Haleon plc | 50 | |
| Tobias Hestler | Haleon plc | 52 | |
| Karen Esq | Intracellular Th | 62 | |
| Josh Coyle | Bausch Health Companies | N/A | |
| JeanJacques Charhon | Bausch Health Companies | 59 | |
| Franck Riot | Haleon plc | 56 | |
| Donald Pearl | Bausch Health Companies | N/A | |
| Ed Petter | Haleon plc | N/A | |
| Claire Dickson | Haleon plc | N/A | |
| Namrata Patel | Haleon plc | 58 | |
| Adrian Morris | Haleon plc | 57 | |
| Bjorn Timelin | Haleon plc | N/A | |
| Willie MD | Intracellular Th | N/A | |
| Graham Jackson | Bausch Health Companies | N/A | |
| Line Decker | Haleon plc | 50 | |
| Arthur Shannon | Bausch Health Companies | N/A | |
| Suresh MD | Intracellular Th | 55 | |
| Aimee Lenar | Bausch Health Companies | N/A | |
Management Performance
| Return On Equity | 0.37 | ||||
| Return On Asset | 0.0628 |
Procaps Group SA Leadership Team
Elected by the shareholders, the Procaps Group's board of directors comprises two types of representatives: Procaps Group inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Procaps. The board's role is to monitor Procaps Group's management team and ensure that shareholders' interests are well served. Procaps Group's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Procaps Group's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Camilo Camacho, Chief Officer | ||
| Sergio Gomez, Chief Officer | ||
| Patricio Vargas, Global Officer | ||
| Marcela Pagano, VicePresident Affairs | ||
| Ruben Minski, Founder Chairman | ||
| Carlos Russo, Head Finance | ||
| Luis Aragon, VicePresident RD | ||
| Jose Vieira, Chief Officer | ||
| Mauricio Caballero, VicePresident Resources | ||
| Melissa Angelini, Investor Director | ||
| Patricio Munoz, Global Officer |
Procaps Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Procaps Group a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Procaps Stock Analysis
When running Procaps Group's price analysis, check to measure Procaps Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Procaps Group is operating at the current time. Most of Procaps Group's value examination focuses on studying past and present price action to predict the probability of Procaps Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Procaps Group's price. Additionally, you may evaluate how the addition of Procaps Group to your portfolios can decrease your overall portfolio volatility.